ArticleTrials2025

Comparison of the effect on treatment satisfaction of switching from multiple insulin injection therapy to additional administration of imeglimin in subjects with type 2 diabetes (MEGMI-TS): study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison trial.

Hiroya Kitsunai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.